A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes
| Autor: | Hollander, Priscilla, Cooper, John, Bregnhøj, Jesper, Pedersen, Claus Bang |
|---|---|
| Zdroj: | In Clinical Therapeutics November 2008 30(11):1976-1987 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect